Edition:
United States

Daxor Corp (DXR.A)

DXR.A on American Stock Exchange

7.19USD
22 Mar 2017
Change (% chg)

-- (--)
Prev Close
$7.19
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,055
52-wk High
$9.80
52-wk Low
$6.81

Latest Key Developments (Source: Significant Developments)

Daxor Corp says Michael Feldschuh appointed Chairman
Thursday, 16 Feb 2017 01:43pm EST 

Daxor Corp : In a unanimous vote Michael Feldschuh was appointed Chairman on Feb 14 - SEC filing .Feldschuh now holds titles of Chairman, Chief Executive Officer, and President of Daxor Corporation.  Full Article

Daxor Corp appointed Michael Feldschuh as CEO
Friday, 23 Sep 2016 06:19am EDT 

Daxor Corp : On September 21, 2016 board appointed Michael Feldschuh as permanent president and CEO of co - SEC filing .Michael has served as acting president and chief executive officer since December, 2015.  Full Article

Daxor Corp announce dividend and leadership changes
Thursday, 10 Dec 2015 08:30am EST 

Daxor Corp:Announces an increased dividend and the appointment of michael feldschuh as president and chief executive officer on a temporary basis.Says board of directors has unanimously approved an increase in the annual dividend payment for 2015, to $0.04 per share.Says joseph feldschuh, president and CEO of Daxor, announced that he will take a medical leave of absence.  Full Article

Daxor Corp announces an update on its stock buyback program and changes in marketing
Thursday, 13 Aug 2015 10:00am EDT 

Daxor Corp:Board of Directors of Daxor Corporation has given management the authority to repurchase up to 250,000 shares of its common stock in 2015.Company can repurchase up to another 123,833 shares before the end of 2015.  Full Article

Daxor Corp receives contract for placement of BVA-100 Blood Volume Analyzer at Lankenau Medical Center
Tuesday, 28 Apr 2015 08:30am EDT 

Daxor Corp:Signs contract from Lankenau Medical Center of Wynnewood, Pennsylvania, for the placement of a BVA-100 Blood Volume Analyzer.  Full Article

Daxor Corp receives two patents
Thursday, 9 Apr 2015 08:30am EDT 

Daxor Corp:Receives approval from the US Patent Office for a Total Body Albumin Analyzer, US Patent # 9,002,656.The patent for the total body albumin analyzer is the first one issued for an instrument to measure the total albumin within the human body.Daxor has also been issued a patent covering new technology used in the automated Blood Volume Analyzer US Patent # 9,002,657.The test for measuring blood volume currently uses five sample points to provide an accurate measurement of a subject's blood volume by measuring the dilution of a tracer in the subject's bloodstream over a thirty-five minute period.  Full Article

More From Around the Web